Wanling Zhu

1.4k total citations · 1 hit paper
42 papers, 1.1k citations indexed

About

Wanling Zhu is a scholar working on Surgery, Endocrine and Autonomic Systems and Molecular Biology. According to data from OpenAlex, Wanling Zhu has authored 42 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Surgery, 16 papers in Endocrine and Autonomic Systems and 12 papers in Molecular Biology. Recurrent topics in Wanling Zhu's work include Pancreatic function and diabetes (19 papers), Regulation of Appetite and Obesity (13 papers) and Sleep and Wakefulness Research (9 papers). Wanling Zhu is often cited by papers focused on Pancreatic function and diabetes (19 papers), Regulation of Appetite and Obesity (13 papers) and Sleep and Wakefulness Research (9 papers). Wanling Zhu collaborates with scholars based in United States, China and Denmark. Wanling Zhu's co-authors include Robert S. Sherwin, Owen Chan, Rory J. McCrimmon, Yuyan Ding, Xiaoning Fan, Adam Horblitt, Sachin Paranjape, Ewan C. McNay, Hai‐Ying Mary Cheng and Margretta R. Seashore and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Diabetes.

In The Last Decade

Wanling Zhu

39 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Metabolic reprogramming of macrophages by a nano-sized opsonization strategy to restore M1/M2 balance for osteoarthritis therapy

2025 19 citations Ruijie Chen, Huirong Huang et al. Journal of Controlled Release profile →

Peers

Countries citing papers authored by Wanling Zhu

Since Specialization

Citations

This map shows the geographic impact of Wanling Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wanling Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wanling Zhu more than expected).

Fields of papers citing papers by Wanling Zhu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wanling Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wanling Zhu. The network helps show where Wanling Zhu may publish in the future.

Co-authorship network of co-authors of Wanling Zhu

This figure shows the co-authorship network connecting the top 25 collaborators of Wanling Zhu. A scholar is included among the top collaborators of Wanling Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wanling Zhu. Wanling Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Adaptive bilirubin nanoscavenger alleviates pulmonary oxidative stress and inflammation for acute lung injury therapy 2025 ·Journal of Advanced Research ·Longfa Kou, (unknown), Shize Li, (unknown), Di Huang, (unknown), (unknown), (unknown), (unknown), Yuqi Yan, (unknown), Wanling Zhu, Xianbao Shi, Hailin Zhang, Ruijie Chen	3
2	Breaking the psoriasis pathological signaling cycle: A novel nanomedicine strategy targeting metabolism and oxidative stress 2025 ·Materials Today Bio ·Fu‐Gen Wu, (unknown), Yuqi Han, (unknown), (unknown), (unknown), (unknown), Dan Shen, (unknown), Wanling Zhu, Ruijie Chen, Xianbao Shi, Xinyu Jiang, Longfa Kou	2
3	Transcriptomic and epigenomic signatures of liver metabolism and insulin sensitivity in aging mice 2025 ·Mechanisms of Ageing and Development ·John Gonzalez, (unknown), Wanling Zhu, (unknown), (unknown), Rachel J. Perry, Albert Higgins‐Chen	0
4	Metabolic reprogramming of macrophages by a nano-sized opsonization strategy to restore M1/M2 balance for osteoarthritis therapy breakdown → 2025 ·Journal of Controlled Release ·Ruijie Chen, (unknown), (unknown), Huirong Huang, (unknown), Chenyu Qiu, Shengjie Li, (unknown), Pengfei Mao, Yuqi Yan, (unknown), (unknown), Wenjing Cai, (unknown), (unknown), Wanling Zhu, Xianbao Shi, Vadivel Ganapathy, Longfa Kou	19
5	P. Gingivalis induce macrophage polarization by regulating hepcidin expression in chronic apical periodontitis 2024 ·International Immunopharmacology ·(unknown), Xuan Chen, Jinglan Zhang, (unknown), Jie Lin, Wanling Zhu, Dingming Huang, Xuelian Tan	6
6	Supramolecular nanoparticle loaded with bilirubin enhances cartilage protection and alleviates osteoarthritis via modulating oxidative stress and inflammatory responses 2024 ·Colloids and Surfaces B Biointerfaces ·(unknown), Huirong Huang, Xinyu Jiang, (unknown), Chenyu Qiu, (unknown), (unknown), Yunzhi Wang, Yuqi Yan, (unknown), (unknown), Wanling Zhu, Fu‐Gen Wu, Xianbao Shi, Ruijie Chen, Longfa Kou	5
7	Enhancing retention and permeation of rapamycin for osteoarthritis therapy using a two-stage drug delivery system 2024 ·Materials Today Bio ·(unknown), Huirong Huang, Meng Sun, (unknown), Shengjie Li, (unknown), Yuqi Yan, Chenyu Qiu, Shize Li, (unknown), Wanling Zhu, Longfa Kou, Ruijie Chen	4
8	Enhancing chemoimmunotherapy for colorectal cancer with paclitaxel and alantolactone via CD44-Targeted nanoparticles: A STAT3 signaling pathway modulation approach 2024 ·Asian Journal of Pharmaceutical Sciences ·Fu‐Gen Wu, (unknown), (unknown), Chenyu Qiu, (unknown), (unknown), (unknown), Yunzhi Wang, Dan Shen, (unknown), (unknown), Wanling Zhu, Xinyu Jiang, (unknown), Ruijie Chen, Longfa Kou	8
9	Photothermal nanocomposite reactivate “immune-hot” for triple-negative breast cancer treatment via glutamine metabolism reprograming 2024 ·Colloids and Surfaces B Biointerfaces ·(unknown), (unknown), (unknown), Chenyu Qiu, (unknown), Lele Li, (unknown), Nuo Chen, (unknown), Zewei Jiang, Wanling Zhu, Fu‐Gen Wu, (unknown), Longfa Kou, Ruijie Chen	2
10	Ferroptosis and tumor immunity: In perspective of the major cell components in the tumor microenvironment 2023 ·European Journal of Pharmacology ·Wanling Zhu, Xiaowei Liu, Lei Yang, Qiang He, Dingming Huang, Xuelian Tan	11
11	Dichloroacetate as a novel pharmaceutical treatment for cancer-related fatigue in melanoma 2023 ·American Journal of Physiology-Endocrinology and Metabolism ·Xinyi Zhang, (unknown), Brooks P. Leitner, Wanling Zhu, (unknown), Zongyu Li, Rafael Calais Gaspar, (unknown), (unknown), Joshua D. Rabinowitz, Rachel J. Perry	9
12	Tissue-specific reprogramming of glutamine metabolism maintains tolerance to sepsis 2023 ·PLoS ONE ·Brooks P. Leitner, Won Dong Lee, Wanling Zhu, Xinyi Zhang, Rafael Calais Gaspar, Zongyu Li, Joshua D. Rabinowitz, Rachel J. Perry	10
13	Gene and protein expression and metabolic flux analysis reveals metabolic scaling in liver ex vivo and in vivo 2023 ·eLife ·Ngozi D. Akingbesote, Brooks P. Leitner, (unknown), Reina Desrouleaux, (unknown), Wanling Zhu, Zongyu Li, Michaël Pollak, Rachel J. Perry	3
14	A precision medicine approach to metabolic therapy for breast cancer in mice 2022 ·Communications Biology ·Ngozi D. Akingbesote, Aaron D. Norman, Wanling Zhu, (unknown), Xinyi Zhang, Julia Foldi, Maryam B. Lustberg, Rachel J. Perry	15
15	Expressions of IL-32 and PCT in serum and alveolar lavage fluid of patients with ICU ventilator-associated pneumonia and their clinical value 2019 ·Central Plains Medical Journal ·Hao Zhang, Wanling Zhu, (unknown)	0
16	Impaired Glutamatergic Neurotransmission in the Ventromedial Hypothalamus May Contribute to Defective Counterregulation in Recurrently Hypoglycemic Rats 2017 ·Diabetes ·Golam M. I. Chowdhury, Peili Wang, (unknown), Ramanaiah Mamillapalli, (unknown), Wanling Zhu, Tore Eid, Kevin L. Behar, Owen Chan	21
17	Type 1 corticotropin-releasing factor receptors in the ventromedial hypothalamus promote hypoglycemia-induced hormonal counterregulation 2007 ·American Journal of Physiology-Endocrinology and Metabolism ·Hai‐Ying Mary Cheng, Ligang Zhou, Wanling Zhu, (unknown), (unknown), Owen Chan, Robert S. Sherwin, Rory J. McCrimmon	26
18	ATP-Sensitive K+ Channels Regulate the Release of GABA in the Ventromedial Hypothalamus During Hypoglycemia 2007 ·Diabetes ·Owen Chan, Marcus A. Lawson, Wanling Zhu, J. Lee Beverly, Robert S. Sherwin	65
19	Effect of acute and recurrent hypoglycemia on regional changes in brain glycogen concentration 2006 ·Diabetes ·Raimund I. Herzog, Ewan C. McNay, Rory J. McCrimmon, Catherine W. Yeckel, Wanling Zhu, Yuyan Ding, (unknown), Xiaoning Fan, Robert S. Sherwin	3
20	DNA Immunization of mice with a plasmid encoding Neisseria gonorrhea PorB protein by intramuscular injection and epidermal particle bombardment 2003 ·Vaccine ·Wanling Zhu, Christopher Thomas, P. Frederick Sparling	34

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact